Literature DB >> 31559467

[Rheumatism and the mind-A mini review].

D Linsmayer1, P-K Neidlinger2, D F Braus2.   

Abstract

BACKGROUND: Rheumatic and mental disorders are common and affect each other. The comorbidities are often diagnosed too late or not at all but cause considerable suffering for those affected and have a negative effect on the health-related quality of life and therapeutic success.
OBJECTIVES: Is there any evidence regarding common pathophysiological mechanisms and how can they be considered in terms of therapy?
METHODS: Recent findings, reviews and basic literature are analyzed and an update is presented and discussed.
RESULTS: The current data suggest a mutual influence of the factors stress and inflammation both in depressive disorders, anxiety disorders and chronic pain, as well as in diseases of the rheumatic type. There is a close relationship between immunological and neuronal processes that bi-directionally regulate the individual's stress response.
CONCLUSIONS: For sufficient therapy the establishment of an interdisciplinary treatment concept in clinical everyday life is to be striven for. In addition to rheumatic treatment, this should include a multimodal approach to both pharmacological and psycho-socio-therapeutic components. In particular, potential interactions must be taken into account.

Entities:  

Keywords:  Antidepressants; Anxiety disorders; Chronic pain; Depression; Inflammation

Mesh:

Substances:

Year:  2019        PMID: 31559467     DOI: 10.1007/s00132-019-03812-8

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  24 in total

Review 1.  Genomics, type 2 diabetes, and obesity.

Authors:  Mark I McCarthy
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

Review 2.  Integrating neuroimmune systems in the neurobiology of depression.

Authors:  Eric S Wohleb; Tina Franklin; Masaaki Iwata; Ronald S Duman
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

3.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

Review 4.  [Patho- and therapyepigenetics of mental disorders].

Authors:  Christiane Ziegler; Miriam A Schiele; Katharina Domschke
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

Review 5.  Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways.

Authors:  John A Sturgeon; Patrick H Finan; Alex J Zautra
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

Review 6.  Interactions between the microbiota, immune and nervous systems in health and disease.

Authors:  Thomas C Fung; Christine A Olson; Elaine Y Hsiao
Journal:  Nat Neurosci       Date:  2017-01-16       Impact factor: 24.884

7.  Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014.

Authors:  Greta A Bushnell; Til Stürmer; Bradley N Gaynes; Virginia Pate; Matthew Miller
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

8.  Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis.

Authors:  Eva-Maria Siegmann; Helge H O Müller; Caroline Luecke; Alexandra Philipsen; Johannes Kornhuber; Teja Wolfgang Grömer
Journal:  JAMA Psychiatry       Date:  2018-06-01       Impact factor: 21.596

Review 9.  Neural mechanisms of social risk for psychiatric disorders.

Authors:  Andreas Meyer-Lindenberg; Heike Tost
Journal:  Nat Neurosci       Date:  2012-04-15       Impact factor: 24.884

Review 10.  A systematic review of comparative efficacy of treatments and controls for depression.

Authors:  Arif Khan; James Faucett; Pesach Lichtenberg; Irving Kirsch; Walter A Brown
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.